Rezolute is currently conducting
the following clinical studies:

An Open-Label Multiple-Dose Study of RZ358 in Patients with Congenital Hyperinsulinism.

Rezolute is committed to ensuring the safety of patients and volunteers who participate in any of our ongoing clinical trials. We strictly follow regulatory requirements to ensure the health and well-being of our participants at all times.

Learn More about RIZE enrollment at the RIZE clinical website.